Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |